@article{article, title  = {{1052 Cost-effectiveness of epoetin alfa (EPO) and darbepoetin alfa (DARB) based on hematopoietic response rates and cost of therapy}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2003}},

 month = {{9}},

 author = {{Van Hout B and Gagnon D and Guastalla J-P}},

 doi = {{10.1016/s1359-6349(03)91078-0}},

 volume = {{1}},

 journal = {{European Journal of Cancer Supplements}},

 issue = {{5}},

 pages = {{S313-S314}},

 note = {{Accessed on 2024/12/22}}}